EUVIMEDEUVIMED entdecken
Crossref

Expression of Melan-A in cutaneous granular cell tumours: a diagnostic pitfall

Victoria I Van Winden, Daniel D Wong, Benjamin A Wood, Pierre Filion, Nathan T Harvey

Pathology · 2024

DOI: 10.1016/j.pathol.2023.09.009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathology, 2024. Verfasst von Victoria I Van Winden und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomical Pathology, PathWest Laboratory Medicine, QEII Medical Centre, Nedlands, WA, Australia. Hauptthemen laut MEDLINE: Melanoma, Granular Cell Tumor, Skin Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Morphological overlap exists between cutaneous granular cell tumours (GCT) and malignant melanoma, with the melanocyte-specific markers HMB45 and Melan-A commonly used to support the diagnosis of melanoma. We recently encountered several cases of GCT in our practice showing strong expression of Melan-A. The aim of this study was to establish the prevalence of positive immunohistochemical staining for Melan-A and HMB45 in a series of unequivocal GCTs. We also aimed to assess the prevalence of staining for PRAME (PReferentially expressed Antigen in MElanoma), a marker expressed in >80% of primary melanomas as well as many non-melanocytic tumours. A total of 20 cutaneous/subcutaneous GCTs were evaluated using Melan-A, HMB45 and PRAME immunohistochemistry. Staining for Melan-A and HMB45 was scored using a semiquantitative scale from 0 (absent) to 3+ (staining present in >50% of tumour cells). PRAME expression was recorded as either positive (>75% of cell nuclei staining) or negative. Melan-A expression was observed in four GCTs (20%), with strong and diffuse (3+) staining seen in two cases (10%), both from anogenital areas. Weak patchy nuclear PRAME expression was seen in every case, interpreted to be negative. HMB45 was also negative in all cases (100%). Our study demonstrates that Melan-A expression can be strong and diffuse in a subset of otherwise unequivocal cutaneous GCTs, which may cause diagnostic confusion with malignant melanoma. HMB45 and PRAME did not stain any of the GCTs in our series.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaGranular Cell TumorSkin NeoplasmsHumansMART-1 AntigenAntigens, NeoplasmBiomarkers, TumorAntibodies, MonoclonalTranscription FactorsDiagnosis, Differential

Stichwörter der Autor:innen

Granular cell tumourHMB45Melan-APRAMEdiagnosisimmunohistochemistrymelanomapathology

Substanzen

MART-1 AntigenAntigens, NeoplasmBiomarkers, TumorAntibodies, MonoclonalTranscription FactorsPRAME protein, human

Autor:innen und Institutionen

  • Department of Anatomical Pathology, PathWest Laboratory Medicine, QEII Medical Centre, Nedlands, WA, Australia.
  • Department of Anatomical Pathology, PathWest Laboratory Medicine, QEII Medical Centre, Nedlands, WA, Australia; School of Medicine, The University of Western Australia, Crawley, WA, Australia.
  • Department of Anatomical Pathology, PathWest Laboratory Medicine, QEII Medical Centre, Nedlands, WA, Australia; School of Medicine, The University of Western Australia, Crawley, WA, Australia. Electronic address: nathan…

Zitieren

APA

Van Winden, V. I., Wong, D. D., Wood, B. A., Filion, P., & Harvey, N. T. (2024). Expression of Melan-A in cutaneous granular cell tumours: a diagnostic pitfall. Pathology. https://doi.org/10.1016/j.pathol.2023.09.009

Vancouver

Van Winden VI, Wong DD, Wood BA, Filion P, Harvey NT. Expression of Melan-A in cutaneous granular cell tumours: a diagnostic pitfall. Pathology. 2024. doi:10.1016/j.pathol.2023.09.009

BibTeX
@article{VanWinden2024,
  author = {Van Winden, Victoria I and Wong, Daniel D and Wood, Benjamin A and Filion, Pierre and Harvey, Nathan T},
  title = {Expression of Melan-A in cutaneous granular cell tumours: a diagnostic pitfall},
  journal = {Pathology},
  year = {2024},
  doi = {10.1016/j.pathol.2023.09.009}
}
Kostenlos starten →